Search

everythinglearnresearchcommunity

for

Search:↓

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Higher iron levels in the blood are not linked to increased hair loss in women.

Finasteride 2.5 mg/day can effectively treat female hair loss.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Menopause affects hair and skin; more research needed for treatment.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Women with PCOS often have liver disease, so liver health checks are important for them.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Most women lack knowledge about androgens and their excess symptoms.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).